
In a study published in Molecular Psychiatry, Mark Frye, M.D., a Mayo Clinic researcher and collaborators, investigated the risk of treatment-emergent mania in bipolar disorder when treated with antidepressants.
"We found that antidepressants that increase mitochondrial energetics (cells that extract energy from nutrients for sustaining life) may elevate the risk of treatment-emergent mania," says Dr. Frye.
The increased energy expenditure of mania associated with impulsivity, poor judgment, psychosis and loss of insight can drive high-risk behaviors, often resulting in hospitalization or incarceration. The aftermath of mania can have an enduring negative effect on the patient's quality of life, explains Dr. Frye, the study's senior author.
Dr. Frye specializes in the neurobiology of bipolar disorders. Bipolar disorder, formerly called manic depression, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression).
"These data suggest categorizing antidepressants based on mitochondrial energetics may be of value," says Dr. Frye.
Read the rest of the article on the Center for Individualized Medicine blog.
____________________________________________
Other Mayo Clinic medical research websites:
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of ...
When Joanina Gicobi began her Ph.D. degree five years ago at Mayo Clinic Graduate School of Biomedical Sciences, she was interested in thinking creatively about ways ...
With age, cells can experience senescence, a state where they stop growing but continue releasing inflammatory and tissue-degrading molecules. When a person is young, the ...